The neurodevelopmental hypothesis of schizophrenia suggests that the disruption of early brain development increases the risk of later developing schizophrenia. While lacking in precise details, this hypothesis focuses attention on critical periods of early brain development. From an epidemiological perspective, various pre-and peri-natal risk factors have been linked to schizophrenia -these include exposures related to infection, nutrition and obstetric complications. From a genetic perspective, candidate genes have also been linked to altered brain development. In recent decades evidence from neuropathology has provided support for the neurodevelopmental hypothesis. In particular, there is evidence implicating disruption of GABA-ergic interneurons in schizophrenia. Animal models involving early life exposures have been linked to changes in these same brain systems, providing convergent evidence for this long-standing hypothesis.
Introduction
In the field of schizophrenia research, it is unusual to find a theory, like the neurodevelopmental hypothesis, that has grown stronger over two to three decades.
This hypothesis, presented in its current formulation nearly a quarter of a century ago, proposes that genetic and/or environmental factors during critical early periods of brain development, adversely impact on adult mental health 1, 2 . Early formulations of this hypothesis proposed that after the developmental insult, the 'lesion' was clinically dormant ('silent') until after puberty, after which maturational events (or other environmental factors, such as cannabis use) were postulated to lead to the emergence of the characteristic psychotic features of schizophrenia. Whether such early exposures produce static (allostasis) or dynamic alterations in brain ontogeny remains an important research question 3 .
The neurodevelopmental hypothesis provided a degree of coherence to a wide range of findings associated with schizophrenia. Several epidemiological clues had implicated early life exposures (e.g. season of birth, obstetric complications).
People with schizophrenia have more minor physical anomalies, suggestive of prenatal disruptions [4] [5] [6] , as well as subtle changes in cognitive and psychological function in early childhood, predating the onset of schizophrenia 7 .
In some respects, the initial formulation of the neurodevelopmental hypothesis was an unsatisfactory guide for research -it lacked a precise form that predicted a particular causal factor or even a particular category of risk factors (e.g., genetic versus nongenetic). Nevertheless, it did provide guidance as to the timing of the key events -it proposed that disruptive events during early brain development (e.g. pre- 4 or peri-natal period, or during the first few years of life), contribute to the risk architecture of schizophrenia. The use of the label 'neurodevelopmental' has led to some debate about static versus progressive encephalopathies 3, 8, 9 . This issue has come into sharper focus in recent years as the MRI evidence has accumulated indicating that schizophrenia is associated with changes in brain volume that predate the onset of the clinical syndrome and continue to change after onset 10, 11 . It is feasible that early disruption of brain development can alter the trajectory of both brain growth and involution across the lifespan.
Clearly, genetic factors are also implicated in the neurodevelopmental hypothesis 12 -major advances have occurred in this field in recent years. In particular, it is now clear that both common single nucleotide polymorphisms (SNPs) and rarer structural variants are associated with an unexpectedly wide range of neuropsychiatric disorders 13 . For example, a large study recently implicated MIR137, a short, noncoding RNA molecule known to regulated dendritic development and the maturation of neurons 14 . Many of these clues have been subsequently investigated in transgenic animal models. However, this topic will not be covered in this review.
Here we will examine evidence for the neurodevelopmental hypothesis from two perspectives; (a) modifiable risk factors from the field of observational epidemiology, and (b) recent developments from neuropathology at the molecular and cellular levels.
Modifiable risk factors for schizophrenia that impact during early life
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Nutrition
Catastrophic prenatal famine has been linked to an increased risk of schizophrenia. Individuals who were in utero during the Dutch famine during World
War II showed an increased risk of schizophrenia and schizophrenia spectrum personality disorders 15 . The finding has been replicated in studies based on a catastrophic famine in China during the Cultural Revolution [16] [17] [18] With respect to the association between risk of schizophrenia and specific maternal micronutrients, elevated homocysteine (a marker of impaired folate metabolism) from maternal third trimester sera has been linked to an increased risk of schizophrenia 19 . Based on clues from season of birth, low prenatal vitamin D has also been proposed as a risk factor for schizophrenia 20 . A recent case-control study lends weight to this candidate 21 . There is now robust evidence from rodent models demonstrating that transient prenatal vitamin D deficiency results in persistent changes in adult brain structure, neurochemistry and behavior [22] [23] [24] [25] [26] [27] . Maternal iron deficiency has also been linked to an increased risk of schizophrenia 28 . Even if altered prenatal nutrition contributes to only a small fraction of those with schizophrenia, the potential to use safe and cheap interventions in at-risk groups makes these candidate exposures attractive from a public health perspective 29 .
Infection
Evidence linking prenatal infection with an increased risk of schizophrenia has accumulated over recent decades 30 . 34, 35 , with mixed evidence for herpes simplex virus type 2 (HSV2) 36, 37 . Evidence from animal models suggests that the prenatal infection may impact on brain development via features of the maternal immune response rather than the direct impact of infectious agents 38 .
Pregnancy and birth complications
Two meta-analyses have examined the association between pregnancy and birth complications and the risk of schizophrenia 39, 40 . Both have found that a diverse range of pregnancy and birth complications are associated with a significant but modest increased risk of later schizophrenia. Based on prospective populationbased studies, Cannon and colleagues 40 reported that the following specific exposures were associated with increased risk of schizophrenia; antepartum haemorrhage, gestational diabetes, rhesus incompatibility, preeclampsia, low birth weight, congenital malformations, reduced head circumference, uterine atony, asphyxia, and emergency caesarean section. Animal models based on these exposure have been informative for schizophrenia research 41, 42 .
Advanced paternal age
The offspring of older fathers have an increased risk of a range of neurodevelopmental disorders, including schizophrenia [43] [44] [45] , autism 46 and epilepsy 47 .
The offspring of older fathers have slightly impaired neurocognitive development during early childhood 48, 49 . With respect to schizophrenia, a meta-analysis 50 reported that the offspring of fathers aged 30 years or older had a significantly increased risk of schizophrenia compared to fathers aged 29 years or younger. The 7 greatest increased risk was found in fathers who were 50 years or older. These findings raise the possibility that an age-related accumulation of de novo mutations in paternal sperm contributes to the risk of schizophrenia. A recent animal model based on advanced paternal age confirmed that the offspring of older male mice had a significantly increased risk of de novo copy number variants 51 . While paternal age may impact on health outcomes via genetic factors, this risk factor is potentially modifiable with public health education (much as has happened with the risks associated with advanced maternal age).
Other risk factors that may impact on early brain development
There is now robust evidence showing that migrant groups in some countries have an increased risk of schizophrenia 52, 53 . Meta-analysis of the primary studies shows that both first and second generation migrants have an increased risk of developing schizophrenia, and that the effect is most pronounced in dark-skinned migrants 53 . Veling and colleagues 54 have recently examined age-at-migration and risk of schizophrenia in first generation migrants. They found that migrants who arrive as babies or infants had the highest risk of schizophrenia, with risk decreasing with age at migration thereafter, such that those who migrated aged 29 years or older had no greater risk of psychotic disorder than the indigenous population. They conclude that the critical window of exposure is during early life.
There is also evidence linking an increased risk of schizophrenia in those who are born and grow up in urban, more densely populated settings (e.g., in populationbased studies from Holland 55 and Denmark   56 ). The evidence suggests that urbanicity of place of birth is a proxy marker for a yet-to-be-identified risk-modifying variable operating at or before birth 57 . However, because most people who are born 8 in a city are also brought up there, it is difficult to disentangle pre-and perinatal effects from those operating later in childhood. Early life stress has also been proposed as a risk factor for schizophrenia 58, 59 .
While this review focuses on early life exposures, it should be noted that puberty is also a critical for brain development and maturation, and exposures during this period have also been linked to risk of schizophrenia. In particular, cannabis use during early teenage years increased the risk of psychotic-related outcomes 60, 61 .
There is also evidence linking exposure to trauma and an increased risk of psychotic-related outcomes [62] [63] [64] .
Neuropathological correlates of schizophrenia -clues related to the neurodevelopmental hypothesis
Findings from morphological and molecular postmortem studies support the hypothesis that schizophrenia is a consequence of a developmental process, and not a degenerative process, affecting the cellular connectivity and network plasticity of the cerebral cortex. Macroscopic morphological studies of postmortem tissue show a reduction in the normal brain asymmetry (or 'torque') 65 in subjects with schizophrenia which, given that brain asymmetries are first apparent prenatally, is consistent with a neurodevelopmental disruption in brain development 
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Disturbances in certain cognitive processes, such as attention, context representation, and working memory, appear to form part of the core clinical landscape of schizophrenia 1, 70 . These cognitive deficits seem to correlate with abnormal activation of the dorsolateral prefrontal cortex (DLPFC) in patients with schizophrenia [71] [72] [73] . At the cellular level, working memory performance requires the precise timing and coordination of activity in subsets of pyramidal neurons in the DLPFC 74 . This "tuning" of pyramidal cells is accomplished by inhibitory inputs from gamma-aminobutyric acid (GABA) interneurons 75, 76 .
Developmental refinements in the connectivity between GABA neurons and pyramidal cells are thought to provide the neural substrate for age-related improvement in working memory performance [77] [78] [79] . Recent findings suggest that working memory impairments in schizophrenia might reflect disturbances in the developmental trajectories of DLPFC synaptic circuitry 80 . Given the protracted nature of these circuitry refinements, a number of different environmental risk factors, acting 10 at different stages of development, could converge on a common pathology. Such alterations, even if minor initially, could become progressively more detrimental as they lead to a diversion from the normal developmental trajectory. In addition, inflection points in these trajectories may delineate periods of increased risk for specific components of cortical circuits.
The ontogeny of cortical GABA interneurons
Interneurons comprise a suite of neurons that display a diverse range of cellular mophologies, laminar distributions, patterns of connectivity and electrophysiologiocal properties. Within the cortex, interneurons contribute approximately 20% of the total neuronal complement. Cortical GABA-ergic interneurons are born in the ganglionic eminence, migrate tangentially into the cortical plate following well-defined pathways [81] [82] [83] [84] [85] , and then vertically into specific cortical layers 86, 87 . In recent years, much work has focused on defining the signalling systems that may influence the migration of these cells -these include such wellknown agents as Slit/Robo, Neuregulin/Erb4, semaphorin/neuropilin and BDNF and NT4 via TrkB receptors. Microarray experiments have also discovered specific genes that are differentially expressed in these cells during migration 88 . Curiously, several of the genes expressed by these cells during migration are of broad interest to schizophrenia. These include ErbB4 89 , Pcdhh8, Nr4a1 (also known as Nur77), Rora, and several genes involved in calcium channels.
Inhibitory GABA neurons in the cerebral cortex can be categorized into different neuronal subtypes defined by the presence of specific molecular, electrophysiological, and/or anatomical properties. Cell type/input-and laminaspecific alterations of pre-and postsynaptic markers of specific circuits formed by 11 certain of these cell types have been found in the DLPFC of subjects with schizophrenia. Early post-mortem studies in patients with schizophrenia revealed an apparent reduction in inhibitory GABA neurons. These findings were largely in the cortex with the most robust changes seen in the calcium-binding protein parvalbumin (PV) containing neurons. However, it was never certain whether such reductions indicated a loss of cells or a down-regulation of the PV marker protein 90 . In particular, widely replicated findings of a reduced expression of GAD67, an enzyme required for the synthesis of GABA at inhibitory synapses, and GAT-1, the protein responsible for the reuptake of GABA at the presynaptic site, suggest alterations in both the synthesis and reuptake of GABA in a subset of DLPFC inhibitory interneurons in schizophrenia [91] [92] [93] . The affected GABA neurons include those that contain PV, and the postsynaptic GABA A receptors that receive inputs from PV neurons are also altered in schizophrenia immune activation [105] [106] [107] , low maternal vitamin D 23, 108 , advanced paternal age 51, 109, 110 , and early life stress 111, 112 . These models express surprisingly high face and 13 predictive validity for schizophrenia. For example, maternal immune activation with the viral mimic Poly-IC leads to a reduction in both Reelin and PV positive interneurons and GABA content in the prefrontal cortex of adult offspring 113, 114 .
Similarly, when pregnant rats were exposed to the bacterial membrane component lipopolysaccharide (LPS) a reduction in both reelin and GAD67 interneurons in the hippocampus of their offspring was revealed 115 . Finally in models of post-adolescent stress, such as social isolation, similar reductions in hippocampal or prefrontal cortical GABAergic neuron structure or content have been found 116, 117 . In summary, there is evidence from animal models to suggest that disruption to GABA interneurons is a shared phenotype associated with diverse genetic and environmental stressors. As such, the orderly development of these cells may be a marker of early brain disruption.
Conclusions
We have previously argued that it is critical that schizophrenia epidemiology is firmly anchored to a neurobiologically-informed framework 118 . While clinical research is clearly important, animal models can play a key role in unravelling the biological mechanisms linking early life disruptions to later neuropsychiatric disorders.
Moreover, animal models provide an experimental platform that allows researchers to focus on more substrate-pure neurobiological correlates of clinical syndromes 119 .
Research inspired by the epidemiological clues such as prenatal nutrition and prenatal infection is likely to lead to the identification of informative pathways.
However, on its own, epidemiology will never be able to address the biocomplexity underpinning a poorly understood group of disorders like schizophrenia. The best returns will come from linking schizophrenia epidemiology with molecular, cellular 14 and behavioural neuroscience. Cross-disciplinary projects related to candidate genetic or nongenetic risk factors can address the biological plausibility of these factors, and can also provide a road to new discoveries in neuroscience. We need to build shared discovery platforms that encourage greater cross-fertilization between schizophrenia epidemiology and basic neuroscience research. We are confident that the neurodevelopmental hypothesis will continue to inspire research in both epidemiology, and neuroscience, and that this journey will continue to provide clues to the neurobiological correlates of schizophrenia.
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BOX 1 Clues from Epidemiology that implicate the neurodevelopmental hypothesis
Excess risk of schizophrenia associated with exposures and proxy markers that could impact on early brain development;  Postsynaptic GABA receptors are also altered; these changes appear to be specific for different subunits and thus types of GABA A receptors.
 Lower expression levels of the gene for GAD67, which is responsible for most GABA synthesis, are found in multiple cortical regions.
